Metabolic syndrome prevalence and its association with the body mass index in university students;Prevalencia de síndrome metabólico y su asociación con el índice de masa corporal en universitarios

Medicina Clinica

Volumn 129, Issue 20, 2007, Pages 766-769

  González Deschamps, Enrique ^a   Palmeros Exsome, Carolina ^b   Villanueva Sánchez, Javier ^b   Torres Flores, Beatriz ^a   Bastida, Sara ^c   Vaquero, M Pilar ^c   Sánchez Muniz, Francisco J ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DEL FRÍO CSIC   (Spain)

Author keywords

Body mass index (BMI); Cardiovascular metabolic syndrome; Young adults

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY STUDENT; WAIST CIRCUMFERENCE;

EID: 37749015686     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13113766     Document Type: Article

References (31)

1. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global Burden of Cardiovascular Diseases: Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-53.
2. Thom T, Haase N, Rosamond W, Howard V, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics - 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85-151 [fe de errores: Circulation. 2006;113:e696; Circulation. 2006;114:e630].
3. INEGI. Estadísticas de mortalidad. Porcentaje de defunciones generales por sexo y principales causas, 1990-2004 [consultado 07/04/2006]. Disponible en: http://www.inegi.gob.mx
4. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al, editores. Encuesta Nacional de Salud II. La salud de los adultos. Tomo 2. Cuernavaca: Instituto Nacional de Salud Pública; 2000.
5. Programa de Acción. Enfermedades cardiovasculares e hipertensión arterial. [consultado 24/06/2006]. Disponible en: http://www.salud.gob.mx/docprog/estrategia_3/enfermedades_cardiovasculares.pdf
6. Ahmed T. State of world population 2005. The promise of equality gender equity, reproductive health and the millennium development goals. New York: United Nations Fund Population; 2005. p. 1-8 [consultado 24/06/2006]. Disponible en: http://www.unfpa.org/swp/2005/pdf/en_swp05.pdf
7. INEGI. XII censo general de población y vivienda, 2000. Tabulados básicos. Aguascalientes: INEGI; 2001 [consultado 24/06/2006]. Disponible en: http://www.inegi.gob.mx
8. Stern MP, Knapp JA, Hazuda HP, Haffner SM, Patterson JK, Mitchell BD. Genetic and environmental determinants of type II diabetes in Mexican Americans. Is there a «descending limb» to the modernization/diabetes relationship? Diabetes Care. 1991;14:649-54.
9. González C, Stern MP, González E, Rivera D, Simón J, Islas S, et al. The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutr Rev. 1999;57:S71-S6.
10. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
11. National Institutes of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda: National Institutes of Health; 2001.
12. Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al. Diagnosis and management of the metabolyc syndrome: an American Heart Association/National Heart, Lung, an Blood Institute Scientific statement. Circulation. 2005;112;2735-52.
13. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation [consultado 24/06/2006]. Disponible en: http://www.idf.org
14. Tzou W, Douglas PM, Srinivasan SR, Bond MG, Tang R, Chen W, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome. J Am Coll Cardiol. 2005;46:457-63.
15. Martín M, Rodríguez-Reguero JJ, Batalla A. Enfermedad coronaria y síndrome metabólico en jóvenes. Med Clin (Barc). 2006;126:514-5.
16. Palomo I, Torres G, Alarcón M, Maragaño P, Leiva E, Mújica V. Alta prevalencia de factores de riesgo cardiovascular clásicos en una población de estudiantes universitarios de la región centro-sur de Chile. Rev Esp Cardiol. 2006;59:1099-105.
17. World Health Organization-International Society of Hypertension. Guidelines for the management of hypertension. Guidelines Subcommittee, 1999 [consultado 22/06/2006]. Disponible en: http://www.eshonline.org/pdf/whoish99. pdf
18. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. NIH Pub. No. 98-4083. Bethesda: National Heart, Lung and Blood Institute; 1998.
19. OMS: FAO-Unicef-WHO. Methodology of nutritional surveillance. Technical Report, serie 53. Geneva: WHO; 1976.
20. Aguilar C, Rojas R, Gómez F, Vallés JM, Franco F, Olaiz G, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004;35:76-81.
21. Daviglus ML. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all cause mortality. JAMA. 2004;292:15888-92.
22. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
23. García F, Pérez M, Gallegos E, Ovalle F. Segundo Congreso Internacional de Nutriología y Obesidad. RESPyN. 2004;7:s/n [consultado 24/06/2006]. Disponible en: http://www.respyn. uanl
24. Tong W, Lai H, Yang C, Ren S, Dai S, Lai S. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults. Int J Cardiol. 2005;104:288-91.
25. Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, et al. Prevalencia del síndrome metabólico en población laboral española. Rev Esp Cardiol. 2005;58:797-806.
26. Real J, Romero P, Martínez S, Pedro T, Carmena R, Ascaso J. Papel de la dislipemia aterogénica en el desarrollo del síndrome metabólico. Med Clin (Barc). 2006;127:321-4.
27. Santi MJ, Carrozas MA, Barba A, Astola A, Jiménez A, Mangas A. Circunferencia de la cintura como predictor de resistencia insulínica en varones jóvenes. Med Clin (Barc). 2005;125:46-50.
28. Kougias P, Chai H, Lin P, Yao Q, Lumsden A, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: Implication of vascular disease. J Surg Res. 2005;126:121-9.
29. Hagg M, Dippenaar N. Dietary fats, fatty acids and insulin resistance: short review of a multifaced connection. Med Sci Monit. 2005;11:RA359-67.
30. Arredondo V. Proyección y consolidación hacia el siglo XXI. Programa de Trabajo 1998-2001 y Programa Operativo Anual 1998. Veracruz: Universidad Veracruzana.
31. SEP. Sistema educativo de los Estados Unidos Mexicanos. Principales cifras. 2003-2004. México DF.